A supplement endorsement offer and a vulnerable client
A dietitian in private practice is offered €3,000 by a supplement company to endorse a 'metabolism booster' on social media. The contract requires two posts, a video testimonial, and before-and-after photographs of clients. The product contains 200 mg caffeine, a proprietary blend, and no ingredient with convincing evidence for weight loss. The company also asks the dietitian to say the product is 'suitable for people with diabetes and kidney disease'. One of the dietitian's clients, a 58-year-old woman with obesity, type 2 diabetes, and stage 3 CKD, has seen the advertisement and asks whether she should buy it. The dietitian has previously posted general healthy-eating content and has 12,000 followers.
1. What ethical issues arise from the endorsement offer, and what should the dietitian do?
Read the worked answer
The offer creates a conflict of interest because payment is contingent on positive public endorsement of a product with weak evidence. Endorsing a 'metabolism booster' with a proprietary blend, 200 mg caffeine, and no convincing weight-loss evidence would overstate benefit. The request to claim suitability for diabetes and kidney disease exceeds the evidence and could cause harm, especially to people with CKD who may have potassium, phosphate, or fluid restrictions. Before-and-after client photographs raise privacy, consent, and dignity concerns and can promote unrealistic body expectations. The dietitian should decline the contract or, at minimum, refuse the unsupported claims, the before-and-after images, and the testimonial involving clients. If any paid relationship were considered, it would need clear disclosure, evidence review, and compliance with advertising and professional rules, but the safest judgement here is to decline. Document the decision and avoid using client cases in marketing without specific consent.
2. How would you counsel the client who asks whether to buy the product?
Read the worked answer
Start by asking what she hopes the product will do and what she has been told. Explain that the product has no reliable evidence for meaningful weight loss, that 200 mg caffeine can raise blood pressure and cause palpitations or insomnia, and that a proprietary blend makes the dose of other ingredients unknown. For her, the 'suitable for diabetes and kidney disease' claim is especially concerning because CKD means she needs individual review of supplements, potassium, phosphate, sodium, and fluid. Do not shame her for asking. Redirect to the plan you can support: evidence-based nutrition, protein and sodium targets, glucose monitoring, physical activity, and review of medications. Warn her about interacting supplements and unregulated products. Give her a simple decision rule: no supplement without checking the full ingredient list, dose, and interactions with her clinician. Document the counselling and her decision.
3. What should the dietitian communicate publicly if approached again by a supplement company?
Read the worked answer
If approached again, the dietitian should ask for the full product specification, evidence dossier, target population, and proposed claims in writing before agreeing to anything. Public communication should distinguish evidence from marketing: state what is known, what is uncertain, and who should avoid the product. Any paid relationship must be prominently disclosed, and claims must not imply treatment or prevention of disease unless legally authorised. The dietitian should avoid client before-and-after images and testimonials that could identify individuals or exploit body-image concerns. If the company will not accept evidence-based wording, decline. Keep a record of the correspondence and the rationale. The professional duty is to protect the public and maintain trust, not to maximise follower engagement or income.